(UDR) UDR - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9026531049
Stock: Apartments, Development, Management
Total Rating 30
Risk 29
Buy Signal -0.48
| Risk 5d forecast | |
|---|---|
| Volatility | 21.9% |
| Relative Tail Risk | 1.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.59 |
| Alpha | -21.06 |
| Character TTM | |
|---|---|
| Beta | 0.528 |
| Beta Downside | 0.990 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.80% |
| CAGR/Max DD | -0.01 |
EPS (Earnings per Share)
Revenue
Description: UDR UDR March 02, 2026
UDR, Inc. (NYSE: UDR) is a S&P 500-listed multifamily REIT that creates shareholder value by acquiring, managing, developing, and redeveloping apartment assets across targeted U.S. markets. As of December 31 2025, the company owned or held interests in 60,941 apartment homes, including 300 units currently under development, reflecting more than five decades of consistent performance.
Recent metrics underscore the firm’s strength: FY 2024 funds-from-operations (FFO) rose 12% year-over-year to $1.20 per share, while the portfolio’s occupancy held at 96% in Q1 2025, and average rent growth outpaced the national multifamily index at 4.5% YoY. The sector remains buoyed by a persistent housing shortage, favorable demographic trends, and relatively stable financing costs despite a modest rise in the Fed Funds rate.
For deeper insights, you might explore ValueRay’s analysis of UDR.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 377.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.96 > 1.0 |
| NWC/Revenue: 6.16% < 20% (prev -26.52%; Δ 32.69% < -1%) |
| CFO/TA 0.09 > 3% & CFO 902.9m > Net Income 377.7m |
| Net Debt (6.15b) to EBITDA (1.03b): 5.98 < 3 |
| Current Ratio: 3.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (332.6m) vs 12m ago 0.42% < -2% |
| Gross Margin: 37.35% > 18% (prev 0.25%; Δ 3710 % > 0.5%) |
| Asset Turnover: 15.93% > 50% (prev 15.34%; Δ 0.58% > 0%) |
| Interest Coverage Ratio: 1.77 > 6 (EBITDA TTM 1.03b / Interest Expense TTM 196.6m) |
Altman Z'' -1.70
| A: 0.01 (Total Current Assets 151.2m - Total Current Liabilities 45.6m) / Total Assets 10.61b |
| B: -0.40 (Retained Earnings -4.24b / Total Assets 10.61b) |
| C: 0.03 (EBIT TTM 348.5m / Avg Total Assets 10.75b) |
| D: -0.65 (Book Value of Equity -4.19b / Total Liabilities 6.46b) |
| Altman-Z'' Score: -1.70 = D |
Beneish M -3.69
| DSRI: 0.59 (Receivables 150.0m/247.8m, Revenue 1.71b/1.67b) |
| GMI: 0.67 (GM 37.35% / 24.94%) |
| AQI: 1.01 (AQ_t 0.97 / AQ_t-1 0.96) |
| SGI: 1.02 (Revenue 1.71b / 1.67b) |
| TATA: -0.05 (NI 377.7m - CFO 902.9m) / TA 10.61b) |
| Beneish M-Score: -3.69 (Cap -4..+1) = AAA |
What is the price of UDR shares?
As of March 02, 2026, the stock is trading at USD 37.50 with a total of 3,852,721 shares traded.
Over the past week, the price has changed by +0.35%, over one month by +2.04%, over three months by +5.13% and over the past year by -14.82%.
Over the past week, the price has changed by +0.35%, over one month by +2.04%, over three months by +5.13% and over the past year by -14.82%.
Is UDR a buy, sell or hold?
UDR has received a consensus analysts rating of 3.57.
Therefor, it is recommend to hold UDR.
- StrongBuy: 5
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the UDR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.9 | 9.1% |
| Analysts Target Price | 40.9 | 9.1% |
UDR Fundamental Data Overview March 01, 2026
P/E Trailing = 33.1858
P/E Forward = 58.1395
P/S = 8.0727
P/B = 3.8565
P/EG = -4.53
Revenue TTM = 1.71b USD
EBIT TTM = 348.5m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 5.82b USD (from longTermDebt, last quarter)
Short Term Debt = 801.7m USD (from shortTermDebt, last quarter)
Debt = 6.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.15b USD (from netDebt column, last quarter)
Enterprise Value = 20.30b USD (14.12b + Debt 6.19b - CCE 1.22m)
Interest Coverage Ratio = 1.77 (Ebit TTM 348.5m / Interest Expense TTM 196.6m)
EV/FCF = 22.49x (Enterprise Value 20.30b / FCF TTM 902.9m)
FCF Yield = 4.45% (FCF TTM 902.9m / Enterprise Value 20.30b)
FCF Margin = 52.73% (FCF TTM 902.9m / Revenue TTM 1.71b)
Net Margin = 22.06% (Net Income TTM 377.7m / Revenue TTM 1.71b)
Gross Margin = 37.35% ((Revenue TTM 1.71b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 26.98% (prev 68.24%)
Tobins Q-Ratio = 1.91 (Enterprise Value 20.30b / Total Assets 10.61b)
Interest Expense / Debt = 0.80% (Interest Expense 49.7m / Debt 6.19b)
Taxrate = 0.02% (37.0k / 238.3m)
NOPAT = 348.5m (EBIT 348.5m * (1 - 0.02%))
Current Ratio = 3.31 (Total Current Assets 151.2m / Total Current Liabilities 45.6m)
Debt / Equity = 1.88 (Debt 6.19b / totalStockholderEquity, last quarter 3.29b)
Debt / EBITDA = 5.98 (Net Debt 6.15b / EBITDA 1.03b)
Debt / FCF = 6.81 (Net Debt 6.15b / FCF TTM 902.9m)
Total Stockholder Equity = 3.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 377.7m / Total Assets 10.61b)
RoE = 11.43% (Net Income TTM 377.7m / Total Stockholder Equity 3.30b)
RoCE = 3.82% (EBIT 348.5m / Capital Employed (Equity 3.30b + L.T.Debt 5.82b))
RoIC = 3.84% (NOPAT 348.5m / Invested Capital 9.07b)
WACC = 5.71% (E(14.12b)/V(20.31b) * Re(7.86%) + D(6.19b)/V(20.31b) * Rd(0.80%) * (1-Tc(0.00)))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF] Terminal Value 86.98% ; FCFF base≈783.8m ; Y1≈838.2m ; Y5≈1.01b
[DCF] Fair Price = 72.73 (EV 30.05b - Net Debt 6.15b = Equity 23.90b / Shares 328.6m; r=5.90% [WACC]; 5y FCF grow 7.76% → 2.90% )
EPS Correlation: 37.36 | EPS CAGR: 112.0% | SUE: 4.0 | # QB: 1
Revenue Correlation: 91.01 | Revenue CAGR: 5.27% | SUE: 3.64 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=-0.005 | Chg30d=-0.031 | Revisions Net=-3 | Analysts=8
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=-0.023 | Chg30d=-0.176 | Revisions Net=-5 | Growth EPS=-62.5% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=0.54 | Chg7d=-0.059 | Chg30d=-0.153 | Revisions Net=-3 | Growth EPS=+27.9% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.9% (Discount Rate 7.9% - Earnings Yield 3.0%)
[Growth] Growth Spread = -3.7% (Analyst 1.3% - Implied 4.9%)
P/E Forward = 58.1395
P/S = 8.0727
P/B = 3.8565
P/EG = -4.53
Revenue TTM = 1.71b USD
EBIT TTM = 348.5m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 5.82b USD (from longTermDebt, last quarter)
Short Term Debt = 801.7m USD (from shortTermDebt, last quarter)
Debt = 6.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.15b USD (from netDebt column, last quarter)
Enterprise Value = 20.30b USD (14.12b + Debt 6.19b - CCE 1.22m)
Interest Coverage Ratio = 1.77 (Ebit TTM 348.5m / Interest Expense TTM 196.6m)
EV/FCF = 22.49x (Enterprise Value 20.30b / FCF TTM 902.9m)
FCF Yield = 4.45% (FCF TTM 902.9m / Enterprise Value 20.30b)
FCF Margin = 52.73% (FCF TTM 902.9m / Revenue TTM 1.71b)
Net Margin = 22.06% (Net Income TTM 377.7m / Revenue TTM 1.71b)
Gross Margin = 37.35% ((Revenue TTM 1.71b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 26.98% (prev 68.24%)
Tobins Q-Ratio = 1.91 (Enterprise Value 20.30b / Total Assets 10.61b)
Interest Expense / Debt = 0.80% (Interest Expense 49.7m / Debt 6.19b)
Taxrate = 0.02% (37.0k / 238.3m)
NOPAT = 348.5m (EBIT 348.5m * (1 - 0.02%))
Current Ratio = 3.31 (Total Current Assets 151.2m / Total Current Liabilities 45.6m)
Debt / Equity = 1.88 (Debt 6.19b / totalStockholderEquity, last quarter 3.29b)
Debt / EBITDA = 5.98 (Net Debt 6.15b / EBITDA 1.03b)
Debt / FCF = 6.81 (Net Debt 6.15b / FCF TTM 902.9m)
Total Stockholder Equity = 3.30b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 377.7m / Total Assets 10.61b)
RoE = 11.43% (Net Income TTM 377.7m / Total Stockholder Equity 3.30b)
RoCE = 3.82% (EBIT 348.5m / Capital Employed (Equity 3.30b + L.T.Debt 5.82b))
RoIC = 3.84% (NOPAT 348.5m / Invested Capital 9.07b)
WACC = 5.71% (E(14.12b)/V(20.31b) * Re(7.86%) + D(6.19b)/V(20.31b) * Rd(0.80%) * (1-Tc(0.00)))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.58%
[DCF] Terminal Value 86.98% ; FCFF base≈783.8m ; Y1≈838.2m ; Y5≈1.01b
[DCF] Fair Price = 72.73 (EV 30.05b - Net Debt 6.15b = Equity 23.90b / Shares 328.6m; r=5.90% [WACC]; 5y FCF grow 7.76% → 2.90% )
EPS Correlation: 37.36 | EPS CAGR: 112.0% | SUE: 4.0 | # QB: 1
Revenue Correlation: 91.01 | Revenue CAGR: 5.27% | SUE: 3.64 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=-0.005 | Chg30d=-0.031 | Revisions Net=-3 | Analysts=8
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=-0.023 | Chg30d=-0.176 | Revisions Net=-5 | Growth EPS=-62.5% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=0.54 | Chg7d=-0.059 | Chg30d=-0.153 | Revisions Net=-3 | Growth EPS=+27.9% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.9% (Discount Rate 7.9% - Earnings Yield 3.0%)
[Growth] Growth Spread = -3.7% (Analyst 1.3% - Implied 4.9%)